We are live on ! Find out more
JWBC

John W. Bristol & Co Portfolio holdings

AUM $6.08B
1-Year Est. Return 16.51%
This Fund
S&P 500
This Quarter Est. Return
+11.27%
1 Year Est. Return
+16.51%
3 Year Est. Return
+77.29%
5 Year Est. Return
+103.39%
10 Year Est. Return
+452.38%
AUM
$4.85B
AUM Growth
+$435M
Cap. Flow
-$19.4M
Cap. Flow %
-0.4%
Top 10 Hldgs %
35.7%
Holding
79
New
2
Increased
5
Reduced
40
Closed
–

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$23.4M
2
BKNG icon
Booking.com
BKNG
+$22.4M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$958K
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$811K
5
ILMN icon
Illumina
ILMN
+$519K

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$25.4M
2
ROP icon
Roper Technologies
ROP
+$24.4M
3
CNQ icon
Canadian Natural Resources
CNQ
+$2.45M
4
AAPL icon
Apple
AAPL
+$1.98M
5
MSFT icon
Microsoft
MSFT
+$1.45M

Sector Composition

Rank Sector Weight
1 Technology 20.41%
2 Consumer Discretionary 17.91%
3 Communication Services 14.49%
4 Financials 13.66%
5 Healthcare 12.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
51
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$1.01M 0.02%
+2,700
New +$958K
SYY icon
52
Sysco
SYY
$40.8B
$899K 0.02%
12,104
– –
MRK icon
53
Merck
MRK
$322B
$845K 0.02%
10,830
– –
DE icon
54
Deere & Co
DE
$165B
$807K 0.02%
3,000
– –
BNY
55
Bank of New York Mellon
BNY
$103B
$802K 0.02%
18,887
– –
MKC icon
56
McCormick & Company Non-Voting
MKC
$14B
$706K 0.01%
7,380
– –
BMY icon
57
Bristol-Myers Squibb
BMY
$129B
$687K 0.01%
11,070
– –
MCD icon
58
McDonald's
MCD
$193B
$633K 0.01%
2,952
– –
GPC icon
59
Genuine Parts
GPC
$17.9B
$593K 0.01%
5,906
– –
ILMN icon
60
Illumina
ILMN
$29.5B
$586K 0.01%
+1,629
New +$519K
PCH
61
DELISTED
PotlatchDeltic
PCH
$554K 0.01%
11,073
– –
PHG icon
62
Philips
PHG
$25.5B
$553K 0.01%
12,580
– –
WY icon
63
Weyerhaeuser
WY
$17.6B
$495K 0.01%
14,761
– –
NSC icon
64
Norfolk Southern
NSC
$75.4B
$475K 0.01%
2,000
– –
AXP icon
65
American Express
AXP
$224B
$444K 0.01%
3,670
– –
MDLZ icon
66
Mondelez International
MDLZ
$82.9B
$439K 0.01%
7,500
– –
PFE icon
67
Pfizer
PFE
$143B
$407K 0.01%
11,070
-598
-5% -$21.9K
KMB icon
68
Kimberly-Clark
KMB
$37.6B
$398K 0.01%
2,952
– –
DAL icon
69
Delta Air Lines
DAL
$56.7B
$378K 0.01%
9,390
– –
D icon
70
Dominion Energy
D
$62.1B
$376K 0.01%
5,000
– –
IBM icon
71
IBM
IBM
$213B
$356K 0.01%
2,960
– –
SNY icon
72
Sanofi
SNY
$107B
$340K 0.01%
7,000
– –
AMGN icon
73
Amgen
AMGN
$209B
$333K 0.01%
1,450
– –
BSX icon
74
Boston Scientific
BSX
$68.4B
$288K 0.01%
8,000
– –
MLM icon
75
Martin Marietta Materials
MLM
$34.2B
$284K 0.01%
1,000
– –
1 2
3
4

Similar funds

EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return

John W. Bristol & Co's Q4 2020 Portfolio in Review

As of Q4 2020, John W. Bristol & Co held 79 positions worth $4.85B, up 9.9% from $4.41B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Trading was light in Q4 2020: portfolio turnover was 2.5%. John W. Bristol & Co opened 2 new positions and made no exits, leaving the 79-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • John W. Bristol & Co's largest Q4 2020 buy was State Street SPDR S&P 500 ETF Trust: 2,700 shares worth $1.01M.
  • John W. Bristol & Co added most to Union Pacific in Q4 2020, an estimated $23.4M increase.
  • John W. Bristol & Co's biggest Q4 2020 reduction was Thermo Fisher Scientific, cutting an estimated $25.4M.
  • John W. Bristol & Co's ten largest holdings make up 36% of its $4.85B portfolio in Q4 2020.
  • John W. Bristol & Co opened 2 new positions and closed 0 in Q4 2020.
  • John W. Bristol & Co's portfolio value rose 9.9% quarter-over-quarter to $4.85B.

Based on John W. Bristol & Co's 13F filing for Q4 2020, filed 5 Feb 2021.